Answer
Oct 23, 2025 - 11:05 AM
Weekly doses ranging from 0.3 mg to 4.5 mg have been investigated, administered subcutaneously. Having a range of dosages allows for personalized treatment based on patient needs and tolerability.
Do you have the same question? Follow this Question
Oct 23, 2025 - 11:05 AM
View all Cagrilintide Questions & Answers